N. Pierrat

552 total citations
35 papers, 391 citations indexed

About

N. Pierrat is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, N. Pierrat has authored 35 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Radiation. Recurrent topics in N. Pierrat's work include Radiation Dose and Imaging (15 papers), Advanced Radiotherapy Techniques (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). N. Pierrat is often cited by papers focused on Radiation Dose and Imaging (15 papers), Advanced Radiotherapy Techniques (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). N. Pierrat collaborates with scholars based in France, Canada and Austria. N. Pierrat's co-authors include Jean‐Marc Cosset, Éric Barret, S. Neuenschwander, Xavier Cathelineau, L. de Carlan, Hervé J. Brisse, François Rozet, Marc Galiano, Didier Franck and Alexia Savignoni and has published in prestigious journals such as Physics in Medicine and Biology, Radiotherapy and Oncology and European Radiology.

In The Last Decade

N. Pierrat

33 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Pierrat France 11 226 198 108 102 41 35 391
Yoshihiro Ida Japan 8 143 0.6× 264 1.3× 104 1.0× 138 1.4× 4 0.1× 35 367
Johannes G. Korporaal Germany 13 128 0.6× 324 1.6× 53 0.5× 155 1.5× 12 0.3× 15 396
Alessandro Vai Italy 11 251 1.1× 116 0.6× 244 2.3× 38 0.4× 14 0.3× 30 355
H. Fendel Germany 8 89 0.4× 167 0.8× 75 0.7× 72 0.7× 4 0.1× 36 290
Panagiotis Baras Greece 13 405 1.8× 423 2.1× 412 3.8× 91 0.9× 12 0.3× 22 666
Graham Hale United States 11 359 1.6× 123 0.6× 22 0.2× 21 0.2× 154 3.8× 28 433
K. Lyttkens Sweden 10 187 0.8× 119 0.6× 18 0.2× 23 0.2× 26 0.6× 34 339
Jannis Bodden Germany 10 48 0.2× 163 0.8× 41 0.4× 129 1.3× 57 1.4× 35 339
J. Jezioranski Canada 12 93 0.4× 84 0.4× 126 1.2× 32 0.3× 93 2.3× 19 353
Y. Rimmer United Kingdom 9 145 0.6× 111 0.6× 131 1.2× 27 0.3× 11 0.3× 23 236

Countries citing papers authored by N. Pierrat

Since Specialization
Citations

This map shows the geographic impact of N. Pierrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Pierrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Pierrat more than expected).

Fields of papers citing papers by N. Pierrat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Pierrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Pierrat. The network helps show where N. Pierrat may publish in the future.

Co-authorship network of co-authors of N. Pierrat

This figure shows the co-authorship network connecting the top 25 collaborators of N. Pierrat. A scholar is included among the top collaborators of N. Pierrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Pierrat. N. Pierrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rouic, Livia Lumbroso‐Le, Raphaël Blanc, Alexia Savignoni, et al.. (2021). Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study. Ophthalmology Retina. 5(8). e30–e37. 5 indexed citations
2.
Masset, H., et al.. (2020). Independent 6D quality assurance of stereotactic radiotherapy repositioning on linacs. Cancer/Radiothérapie. 24(3). 199–205. 3 indexed citations
3.
Hannoun‐Lévi, Jean‐Michel, Pierre Blanchard, Cyrus Chargari, et al.. (2020). Curiethérapie en France en 2020 : synthèse et perspectives du Groupe curiethérapie de la Société française de radiothérapie oncologique. Cancer/Radiothérapie. 24(8). 876–881. 5 indexed citations
4.
Pierrat, N., et al.. (2019). Patient dose evaluation in computed tomography: A French national study based on clinical indications. Physica Medica. 61. 18–27. 30 indexed citations
5.
Fitton, Isabelle, et al.. (2019). Experimental evaluation of seven quality control phantoms for digital breast tomosynthesis. Physica Medica. 57. 137–144. 10 indexed citations
6.
Lalande, Alain, Igor Bessières, N. Pierrat, et al.. (2018). Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images. Brachytherapy. 17(6). 866–873. 3 indexed citations
7.
Srougi, Victor, Éric Barret, Igor Nunes‐Silva, et al.. (2017). Focal brachytherapy for localized prostate cancer: Urinary toxicity depends on tumor location. Brachytherapy. 16(5). 988–992. 24 indexed citations
8.
Cosset, Jean‐Marc, T Flam, Lisa Belin, et al.. (2016). Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003. Cancer/Radiothérapie. 20(4). 261–267. 29 indexed citations
9.
Isambert, A., et al.. (2014). Medical physics personnel for medical imaging: requirements, conditions of involvement and staffing levels--French recommendations. Radiation Protection Dosimetry. 164(1-2). 130–133. 3 indexed citations
11.
Pierrat, N., et al.. (2013). Calcul de la distribution de dose en curiethérapie. Cancer/Radiothérapie. 17(2). 89–92. 6 indexed citations
12.
Cosset, Jean‐Marc, Jean‐Michel Hannoun‐Lévi, D. Peiffert, et al.. (2013). Curiethérapie du cancer prostatique par implants permanents : le point en 2013. Cancer/Radiothérapie. 17(2). 111–117. 12 indexed citations
13.
Broggio, David, Alexandra Moignier, Anna Gardumi, et al.. (2013). Comparison of organs’ shapes with geometric and Zernike 3D moments. Computer Methods and Programs in Biomedicine. 111(3). 740–754. 8 indexed citations
14.
Cosset, Jean‐Marc, Éric Barret, Xavier Cathelineau, et al.. (2011). One-step customized transurethral resection of the prostate and permanent implant brachytherapy for selected prostate cancer patients: Technically feasible but too toxic. Brachytherapy. 10(1). 29–34. 7 indexed citations
16.
Cosset, Jean‐Marc, T Flam, Nicolas Thiounn, et al.. (2008). La curiethérapie du cancer prostatique par implants permanents. Cancer/Radiothérapie. 12(6-7). 503–511. 7 indexed citations
17.
Franck, Didier, L. de Carlan, N. Pierrat, David Broggio, & Stéphanie Lamart. (2007). OEDIPE: a new graphical user interface for fast construction of numerical phantoms and MCNP calculations. Radiation Protection Dosimetry. 127(1-4). 262–265. 9 indexed citations
18.
Franck, Didier, et al.. (2006). Potential of modern technologies for improvement of in vivo calibration. Radiation Protection Dosimetry. 125(1-4). 438–443. 5 indexed citations
19.
Pierrat, N., et al.. (2006). Determination of new European biometric equations for the calibration of in vivo lung counting systems using the Livermore phantom. Radiation Protection Dosimetry. 125(1-4). 449–455. 3 indexed citations
20.
Franck, Didier, et al.. (2003). Application of Monte Carlo calculations to calibration of anthropomorphic phantoms used for activity assessment of actinides in lungs. Radiation Protection Dosimetry. 105(1-4). 403–408. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026